2004;36:674 9. 53. Ho H-H, Siu C-W, Yiu K-H, et al. Prosthetic valve endocarditis in a mul- ticenter registry of Chinese patients. Asian Cardiovasc Thorac Ann. 2010;18:430 4. 54. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a sci- entific statement from the American Heart Association. Circulation. 2010;121:458 77. 55. Viganego F, O Donoghue S, Eldadah Z, et al. Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections. Am J Cardiol. 2012;109:1466 71. 56. Rudasill SE, Sanaiha Y, Mardock AL, et al. Clinical outcomes of in- fective endocarditis in injection drug users. J Am Coll Cardiol. 2019;73:559 70. 57. Rodger L, Glockler-Lauf SD, Shojaei E, et al. Clinical characteristics and factors associated with mortality in first-episode infective endocarditis among persons who inject drugs. JAMA Netw Open. 2018;1:e185220. 58. Schranz AJ, Fleischauer A, Chu VH, et al. Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data. Ann Intern Med. 2019;170:31 40. 59. Rosenthal ES, Karchmer AW, Theisen-Toupal J, et al. Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis. Am J Med. 2016;129:481 5. 60. Liebschutz JM, Crooks D, Herman D, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174:1369 76. 61. Kang D-H, Kim Y-J, Kim S-H, et al. Early surgery versus conventional treat- ment for infective endocarditis. N Engl J Med. 2012;366:2466 73. 62. Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in in- fective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation. 2005;112:69 75. 63. M gge A, Daniel WG, Frank G, et al. 